🇺🇸 US JNJ

Johnson & Johnson — Investment Thesis & Equity Research

🏢 Johnson & Johnson ✍️ AiAlphaLens Research 📅 March 23, 2026

Research Summary

Johnson & Johnson (JNJ) reported revenue of $94.19B and net profit of $26.80B. Revenue grew 9.1% YoY with a net profit margin of 28.5%. The company maintains strong positioning in the Healthcare sector. BUY | PT USD 277.74 (+18.0% upside).

Read the Full Research Report

Access the complete analysis, financial model, price target breakdown, and risk factors.

Read Full Report →

2 free reads per day · No credit card required